Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest SignalingJui‐Ling Hsu(National Taiwan University), Jih‐Hwa Guh(National Taiwan University)Frontiers in OncologyAugust 7, 202010.3389/fonc.2020.01274Cited by 26SaveCiteExport RISWatch citationsRelated PapersRepurposing of nitroxoline as a potential anticancer agent against human prostate cancer - a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation|Oncotarget|2015|492‐Phenyl‐5‐(pyrrolidin‐1‐yl)‐1‐(3,4,5‐trimethoxybenzyl)‐1 <i>H</i> ‐benzimidazole, a benzimidazole derivative, inhibits growth of human prostate cancer cells by affecting tubulin and c‐Jun N‐terminal kinase|British Journal of Pharmacology|2010|28Reevesioside A, a Cardenolide Glycoside, Induces Anticancer Activity against Human Hormone-Refractory Prostate Cancers through Suppression of c-myc Expression and Induction of G1 Arrest of the Cell Cycle|PLoS ONE|2014|28<i>Epi</i>-reevesioside F inhibits Na+/K+-ATPase, causing cytosolic acidification, Bak activation and apoptosis in glioblastoma|Oncotarget|2015|11